de Duve Institute
Laurence de Villenfagne is currently a PhD student at the de Duve Institute, specializing in studying PDGFRα receptor mutations for improved targeting in brain tumors under the guidance of Pr. Jean-Baptiste Demoulin since October 2022. Prior research experience includes a research internship at the Institut de recherches cliniques de Montréal (IRCM) from March to June 2022, focusing on the PEAK1/RASAL2 complex's role in triple negative breast cancer metastasis in Pr. Jean-Francois Côté's laboratory. Laurence also completed a Master Thesis Project at the de Duve Institute from February 2021 to January 2022, following a Master's degree in Biomedical Sciences with a focus on cancerology from Université catholique de Louvain and a Bachelor's degree in Biomedical Sciences from Université de Namur. Early education concluded with a high school diploma from Institut Saint-André d'Ixelles.
de Duve Institute
Founded by Nobel laureate Christian de Duve, the de Duve Institute is a multidisciplinary biomedical research institute bringing together more than 250 researchers and technicians from close to 40 countries on the UCLouvain campus in Brussels, who strive to better understand diseases in order to better cure them. To achieve this goal, research at the Institute is based on three principles: priority to basic research and to the freedom of the investigators, focus on medical benefits resulting from basic discoveries, special attention to collaborative and interdisciplinary research. Current research at the de Duve Institute is covering many areas of basic biomedical research, with the aim to improve the diagnosis and treatment of: - Cancers, leukemias and lymphomas, and their treatment with immunotherapy; - Acquired (diabetes) and hereditary (rare diseases) metabolic diseases; - Diseases related to immunity disorders (asthma, multiple sclerosis, systemic scleroderma, Crohn's disease, psoriasis); - Viral and bacterial infections, with a major research focus on the development of new antibiotics and new ways to fight bacteria; - Developmental disorders of vascular (angioma, lymphedema) and skeletal (cleft lip) systems. To keep abreast of our current events and discoveries, follow us on: https://www.facebook.com/deDuveInstitute/ https://www.youtube.com/channel/UCUtTsc5mO6rZaEP7ZFLcXrQ https://twitter.com/deDuveInstitute https://www.instagram.com/deduveinstitute1974/